Want to join the conversation?
During 4Q16, $CTLT said that OPKO Health's NDA for RAYALDEE drug was approved by the FDA for the treatment of patients with conditions related to chronic kidney disease. This marks the first FDA approved product using the company's proprietary OptiShell softgel technology, which is a non-gelatin plant-based shell formulation.
The latest earnings report by $VZ shows how it is losing customers despite offering the unlimited data plans, a record for the company.
$BEBE is closing down all its stores by the end of May.
$WFC agreed to hike its payout in a class-action settlement over unauthorized accounts by $32 million to $142 million for its retail sales practices. The settlement will now include customers who were impacted as early as May 2002.